|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-2-5
|
|
pubmed:abstractText |
Clear cell adenocarcinoma of the ovary often shows resistance to anticancer agents. It accounts for 20% of epithelial ovarian cancer in Japan versus around 5% in other countries. We investigated new molecules to use when developing molecular-targeting therapy for clear cell adenocarcinoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Multienzyme Complexes,
http://linkedlifedata.com/resource/pubmed/chemical/POU Domain Factors,
http://linkedlifedata.com/resource/pubmed/chemical/POU6F1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphodiesterase I,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphoric Diester Hydrolases,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrophosphatases,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Lysophosphatidic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/alkylglycerophosphoethanolamine...
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1525-1438
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
212-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:20134265-Adenocarcinoma, Clear Cell,
pubmed-meshheading:20134265-Animals,
pubmed-meshheading:20134265-Cell Line, Tumor,
pubmed-meshheading:20134265-Cell Proliferation,
pubmed-meshheading:20134265-Female,
pubmed-meshheading:20134265-Humans,
pubmed-meshheading:20134265-Male,
pubmed-meshheading:20134265-Mice,
pubmed-meshheading:20134265-Mice, Inbred BALB C,
pubmed-meshheading:20134265-Mice, Nude,
pubmed-meshheading:20134265-Multienzyme Complexes,
pubmed-meshheading:20134265-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:20134265-Ovarian Neoplasms,
pubmed-meshheading:20134265-POU Domain Factors,
pubmed-meshheading:20134265-Phosphodiesterase I,
pubmed-meshheading:20134265-Phosphoric Diester Hydrolases,
pubmed-meshheading:20134265-Pyrophosphatases,
pubmed-meshheading:20134265-RNA, Small Interfering,
pubmed-meshheading:20134265-Receptors, Lysophosphatidic Acid
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Transcription factor POU6F1 is important for proliferation of clear cell adenocarcinoma of the ovary and is a potential new molecular target.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, St Marianna University School of Medicine, Kanagawa, Japan. nao@marianna-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
